WebMar 25, 2024 · According to ZoomInfo records, Steve Schoch’s professional experience began in 1998. Since then Steve has changed 6 companies and 6 roles. Work Experience Chief Operating Officer & Chief Financial Officer FLYR 2024-2024 Chief Financial Officer 23andMe 2024-2024 Chief Executive Officer Miramax 2010-2016 Managing Director Clear … Webpresenters today will be Anne Wojcicki, the co-founder and CEO of 23andMe, Steve Schoch, the Chief Financial Officer, and Kenneth Hillan, the Head of Therapeutics. 00:00:35:14 They will take you through the presentation. of what our investment thesis is for 23andMe and why we're so excited about partnering with this company to help them go public.
Stephen Schoch – Virginia Cavaliers Official Athletic Site
WebSince its $400 million acquisition of telehealth platform developer and telepharmacy services company Lemonaid Health last November, 23andMe has started expanding beyond its core consumer genetic testing into a new business line called its genomic health service. "Developing our genomic health service for our customers remains a high priority for our … WebAug 13, 2024 · Therapeutics made up 47% of its $44.2 million in first-quarter R&D spending this year, compared to 37% during the same period last year. "We're putting our back into it," CFO Steve Schoch said... cps tree trimming
Investor Relations 23andMe, Inc
WebJun 2, 2024 · "With his extensive background developing and implementing strategic investor relations programs within the biotech space, we are confident that Wade is the … WebAug 13, 2024 · Still, 23andMe leaders are clearly excited about the first drug wholly owned by the company entering the clinic by the end of March, which is the end of the company's … WebAug 19, 2024 · By Samuel O'Brient, InvestorPlace Financial News Writer Aug 19, 2024, 11:42 am EDT. 23andMe ( ME) stock is falling today on major executive shift news. CFO Steven Schoch will be stepping down from ... cpstring